Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Radial access during PAD interventions | More details on the big policy shift in carotid stenting | Heart-healthy diets
Monday, October 23, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Radial access shows potential to ‘revolutionize’ care for peripheral artery disease

Radial access provides interventional cardiologists with a safe, effective alternative to femoral access during peripheral artery interventions.

READ MORE >
surgery.jpg
Share on Twitter Share on Facebook Share on Linkedin

Radial access shows potential to ‘revolutionize’ care for peripheral artery disease

Share on Twitter Share on Facebook Share on Linkedin
surgery.jpg
Radial access provides interventional cardiologists with a safe, effective alternative to femoral access during peripheral artery interventions.
READ MORE >

Q&A: Ken Rosenfield explains the impact of new reimbursement coverage for carotid stenting 

Ken Rosenfield, MD, helped spearhead the recent Medicare policy change that made carotid stenting procedures available to more patients.

READ MORE >
Ken Rosenfield, MD, Mass General Hospital, explains the impact wider CMS reimbursement for carotid artery stenting will have on patient stroke care and interventional cardiology. CAS
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Ken Rosenfield explains the impact of new reimbursement coverage for carotid stenting 

Share on Twitter Share on Facebook Share on Linkedin
Ken Rosenfield, MD, Mass General Hospital, explains the impact wider CMS reimbursement for carotid artery stenting will have on patient stroke care and interventional cardiology. CAS
Ken Rosenfield, MD, helped spearhead the recent Medicare policy change that made carotid stenting procedures available to more patients.
READ MORE >

Heart-healthy diets may help women limit signs of cognitive decline later in life

More than 5,000 women were interviewed about their eating habits from 1985 to 1991, and then researchers followed up with them 30 years later. The full study was published in Alzheimer’s and Dementia.

READ MORE >
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.
Share on Twitter Share on Facebook Share on Linkedin

Heart-healthy diets may help women limit signs of cognitive decline later in life

Share on Twitter Share on Facebook Share on Linkedin
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.
More than 5,000 women were interviewed about their eating habits from 1985 to 1991, and then researchers followed up with them 30 years later. The full study was published in Alzheimer’s and Dementia.
READ MORE >

Featured Articles

Edwards gains CE mark approval for new tricuspid valve replacement device

The approval represents a significant moment in the treatment of structural heart disease. Edwards will share updated data on the device at TCT 2023 in San Francisco.  

READ MORE >
Edwards Lifesciences gained European CE mark approval for Evoque transcatheter tricuspid valve replacement (TTVR) system.
Share on Twitter Share on Facebook Share on Linkedin

Edwards gains CE mark approval for new tricuspid valve replacement device

Share on Twitter Share on Facebook Share on Linkedin
Edwards Lifesciences gained European CE mark approval for Evoque transcatheter tricuspid valve replacement (TTVR) system.
The approval represents a significant moment in the treatment of structural heart disease. Edwards will share updated data on the device at TCT 2023 in San Francisco.  
READ MORE >

Cardiologist in Israel suspended for alleged support of Hamas—doctor maintains innocence

The doctor says the social media post that led to his suspension was taken out of context. "I have not supported, do not support and will not support acts of terrorism," he said. 

READ MORE >
Israel Flag
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist in Israel suspended for alleged support of Hamas—doctor maintains innocence

Share on Twitter Share on Facebook Share on Linkedin
Israel Flag
The doctor says the social media post that led to his suspension was taken out of context. "I have not supported, do not support and will not support acts of terrorism," he said. 
READ MORE >

Cardiologist-founded virtual cardiology clinic raises $8M to expand heart failure offerings

The company hopes this new round of funding from private-equity investors will help its home-based care model flourish and reach more patients than ever before. 

READ MORE >
Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist-founded virtual cardiology clinic raises $8M to expand heart failure offerings

Share on Twitter Share on Facebook Share on Linkedin
Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 
The company hopes this new round of funding from private-equity investors will help its home-based care model flourish and reach more patients than ever before. 
READ MORE >

In Case You Missed It

New TAVR system for pure aortic regurgitation used for first time, linked to ‘excellent’ short-term outcomes

Researchers explored data from the first 10 patients treated with a new self-expanding TAVR device from KOKA Lifesciences. After 30 days, there were no patient deaths and only one adverse event.

READ MORE >
The Pioneer TAVR system from KOKA Lifesciences
Share on Twitter Share on Facebook Share on Linkedin

New TAVR system for pure aortic regurgitation used for first time, linked to ‘excellent’ short-term outcomes

Share on Twitter Share on Facebook Share on Linkedin
The Pioneer TAVR system from KOKA Lifesciences
Researchers explored data from the first 10 patients treated with a new self-expanding TAVR device from KOKA Lifesciences. After 30 days, there were no patient deaths and only one adverse event.
READ MORE >

Haemonetics to acquire medical device company known for its TAVR guidewires for $253M

Haemonetics expects the deal to increase its short- and long-term revenue. The all-cash transaction should close by January 2024.

READ MORE >
The SavvyWire TAVR guidewire by OpSens / Haemonetics
Share on Twitter Share on Facebook Share on Linkedin

Haemonetics to acquire medical device company known for its TAVR guidewires for $253M

Share on Twitter Share on Facebook Share on Linkedin
The SavvyWire TAVR guidewire by OpSens / Haemonetics
Haemonetics expects the deal to increase its short- and long-term revenue. The all-cash transaction should close by January 2024.
READ MORE >

In Other News

FDA highlights radiology's continued dominance in AI-enabled device submissions

Through the end of July, 79% of all AI products authorized by the agency in 2023 are in radiology, followed by 9% in cardiovascular care, and 5% in neurology. 

READ MORE >
artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

FDA highlights radiology's continued dominance in AI-enabled device submissions

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence
Through the end of July, 79% of all AI products authorized by the agency in 2023 are in radiology, followed by 9% in cardiovascular care, and 5% in neurology. 
READ MORE >

Amazon Pharmacy now delivering medications by drone, promising orders in 1 hour or less

The new service is now live in College Station, Texas. The drones use a series of sensors and cameras to remain stable and navigate around obstacles as needed.

READ MORE >
Amazon Pharmacy is now delivering medications by done
Share on Twitter Share on Facebook Share on Linkedin

Amazon Pharmacy now delivering medications by drone, promising orders in 1 hour or less

Share on Twitter Share on Facebook Share on Linkedin
Amazon Pharmacy is now delivering medications by done
The new service is now live in College Station, Texas. The drones use a series of sensors and cameras to remain stable and navigate around obstacles as needed.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup